Janney Montgomery Scott
MIRM icon

Janney Montgomery Scott’s Mirum Pharmaceuticals MIRM Stock Holding History

Janney Montgomery Scott’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Buy
5,178
+2,278
+79% +$229K ﹤0.01% 2266
2026
Q1 		$268K Sell
2,900
-300
-9% -$28.2K ﹤0.01% 2463
2025
Q4 		$253K Buy
3,200
+200
+7% +$14.4K ﹤0.01% 2664
2025
Q3 		$220K Buy
+3,000
New +$191K ﹤0.01% 2682
2024
Q2 		– Sell
-14,812
Closed -$372K – 2737
2024
Q1 		$372K Sell
14,812
-9,288
-39% -$255K ﹤0.01% 2196
2023
Q4 		$711K Buy
24,100
+5,175
+27% +$157K ﹤0.01% 1663
2023
Q3 		$598K Buy
18,925
+950
+5% +$26K ﹤0.01% 1649
2023
Q2 		$465K Buy
17,975
+100
+0.6% +$2.66K ﹤0.01% 1913
2023
Q1 		$429K Sell
17,875
-450
-2% -$10.3K ﹤0.01% 1814
2022
Q4 		$357K Sell
18,325
-1,100
-6% -$21.7K ﹤0.01% 1990
2022
Q3 		$408K Buy
19,425
+2,700
+16% +$65K ﹤0.01% 1822
2022
Q2 		$308K Buy
16,725
+3,100
+23% +$73.1K ﹤0.01% 1901
2022
Q1 		$300K Buy
+13,625
New +$278K ﹤0.01% 1880

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janney Montgomery Scott's MIRM Position: Q2 2026 in Review

Janney Montgomery Scott increased its Mirum Pharmaceuticals (MIRM) stake by 79% in Q2 2026, buying an estimated $229K and bringing the position to 5,178 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Janney Montgomery Scott first reported a position in MIRM in Q1 2022 and has held it in 13 quarters since. The position peaked at $711K in Q4 2023. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Janney Montgomery Scott held 5,178 shares of Mirum Pharmaceuticals worth $606K as of Q2 2026.
  • Janney Montgomery Scott bought 2,278 Mirum Pharmaceuticals shares in Q2 2026, an estimated $229K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2266 holding.
  • Janney Montgomery Scott first reported a position in Mirum Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
  • Janney Montgomery Scott's Mirum Pharmaceuticals position peaked at $711K in Q4 2023.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.